Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Revisiting the role of ABC transporters in multidrug-resistant cancer.

Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM.

Nat Rev Cancer. 2018 Jul;18(7):452-464. doi: 10.1038/s41568-018-0005-8. Review.

2.

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.

Fan YF, Zhang W, Zeng L, Lei ZN, Cai CY, Gupta P, Yang DH, Cui Q, Qin ZD, Chen ZS, Trombetta LD.

Cancer Lett. 2018 May 1;421:186-198. doi: 10.1016/j.canlet.2018.01.021. Epub 2018 Jan 11.

PMID:
29331420
3.

Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.

Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.

Int J Cancer. 2002 Feb 20;97(6):751-60.

4.

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.

Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR Jr, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW.

Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499. Erratum in: Cancer Res. 2008 Dec 15;68(24):10387.

5.

Expression of multidrug resistance-related transporters in human breast carcinoma.

Kanzaki A, Toi M, Nakayama K, Bando H, Mutoh M, Uchida T, Fukumoto M, Takebayashi Y.

Jpn J Cancer Res. 2001 Apr;92(4):452-8.

6.

5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.

Ranjbar S, Khonkarn R, Moreno A, Baubichon-Cortay H, Miri R, Khoshneviszadeh M, Saso L, Edraki N, Falson P, Firuzi O.

Toxicol Appl Pharmacol. 2019 Jan 1;362:136-149. doi: 10.1016/j.taap.2018.10.025. Epub 2018 Nov 2.

PMID:
30391378
7.

The role of ABC transporters in clinical practice.

Leonard GD, Fojo T, Bates SE.

Oncologist. 2003;8(5):411-24. Review.

8.

Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.

Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH.

Oncol Rep. 2009 Jul;22(1):65-71.

PMID:
19513506
9.

Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.

Takebayashi Y, Nakayama K, Fujioka T, Kanzaki A, Mutho M, Uchida T, Miyazaki K, Ito M, Fukumoto M.

Int J Mol Med. 2001 Apr;7(4):397-400.

PMID:
11254880
10.

Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.

Li S, Zhang W, Yin X, Xing S, Xie HQ, Cao Z, Zhao B.

Anticancer Agents Med Chem. 2015;15(4):423-32. Review.

PMID:
25929575
12.

Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Andersen V, Svenningsen K, Knudsen LA, Hansen AK, Holmskov U, Stensballe A, Vogel U.

World J Gastroenterol. 2015 Nov 7;21(41):11862-76. doi: 10.3748/wjg.v21.i41.11862.

13.

β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.

Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC.

Phytomedicine. 2016 Mar 15;23(3):316-23. doi: 10.1016/j.phymed.2016.01.008. Epub 2016 Feb 6.

PMID:
26969385
14.

Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.

Chen M, Xue X, Wang F, An Y, Tang D, Xu Y, Wang H, Yuan Z, Gao W, Wei J, Zhang J, Miao Y.

Oncol Rep. 2012 Jan;27(1):265-9. doi: 10.3892/or.2011.1475. Epub 2011 Sep 28.

PMID:
21956451
15.

Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.

Shi Z, Peng XX, Kim IW, Shukla S, Si QS, Robey RW, Bates SE, Shen T, Ashby CR Jr, Fu LW, Ambudkar SV, Chen ZS.

Cancer Res. 2007 Nov 15;67(22):11012-20.

16.
17.

Relevance of multidrug resistance in the age of targeted therapy.

Türk D, Szakács G.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):246-52. Review.

PMID:
19333870
18.

[Drug resistance mediated by ABC transporters].

Yoshikawa M, Ito A, Ishikawa T, Ikegami Y.

Gan To Kagaku Ryoho. 2004 Jan;31(1):1-6. Review. Japanese.

PMID:
14750312
19.

ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.

Lazarowski A, Czornyj L, Lubienieki F, Girardi E, Vazquez S, D'Giano C.

Epilepsia. 2007;48 Suppl 5:140-9. Review. Erratum in: Epilepsia. 2007 Dec;48(12):2380.

20.

ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.

Cotte S, von Ahsen N, Kruse N, Huber B, Winkelmann A, Zettl UK, Starck M, König N, Tellez N, Dörr J, Paul F, Zipp F, Lühder F, Koepsell H, Pannek H, Montalban X, Gold R, Chan A.

Brain. 2009 Sep;132(Pt 9):2517-30. doi: 10.1093/brain/awp164. Epub 2009 Jul 15.

PMID:
19605531

Supplemental Content

Support Center